NO20053624L - Tetrahydro-4H-pyrido [1,2-A] pyrimidiner og beslektede forbindelser som er anvendbare som HIV-integrase inhibitorer - Google Patents
Tetrahydro-4H-pyrido [1,2-A] pyrimidiner og beslektede forbindelser som er anvendbare som HIV-integrase inhibitorerInfo
- Publication number
- NO20053624L NO20053624L NO20053624A NO20053624A NO20053624L NO 20053624 L NO20053624 L NO 20053624L NO 20053624 A NO20053624 A NO 20053624A NO 20053624 A NO20053624 A NO 20053624A NO 20053624 L NO20053624 L NO 20053624L
- Authority
- NO
- Norway
- Prior art keywords
- compounds
- pyrido
- pyrimidines
- tetrahydro
- hiv
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 6
- UBOXAHWUKQXQEH-UHFFFAOYSA-N 2,3,4,6-tetrahydro-1h-pyrido[1,2-a]pyrimidine Chemical class C1=CCN2CCCNC2=C1 UBOXAHWUKQXQEH-UHFFFAOYSA-N 0.000 title abstract 2
- 229940099797 HIV integrase inhibitor Drugs 0.000 title 1
- 239000003084 hiv integrase inhibitor Substances 0.000 title 1
- 208000030507 AIDS Diseases 0.000 abstract 2
- 239000003112 inhibitor Substances 0.000 abstract 2
- 230000002265 prevention Effects 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 208000031886 HIV Infections Diseases 0.000 abstract 1
- 108010002459 HIV Integrase Proteins 0.000 abstract 1
- 208000037357 HIV infectious disease Diseases 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 229940088710 antibiotic agent Drugs 0.000 abstract 1
- 239000003443 antiviral agent Substances 0.000 abstract 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 abstract 1
- 239000002955 immunomodulating agent Substances 0.000 abstract 1
- 229940121354 immunomodulator Drugs 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 229940042443 other antivirals in atc Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000010076 replication Effects 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43683002P | 2002-12-27 | 2002-12-27 | |
| US52877603P | 2003-12-12 | 2003-12-12 | |
| PCT/GB2003/005543 WO2004058757A1 (en) | 2002-12-27 | 2003-12-18 | Tetrahydro-4h-pyrido[1,2-a]pyrimidines and related compounds useful as hiv integrase inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20053624D0 NO20053624D0 (no) | 2005-07-26 |
| NO20053624L true NO20053624L (no) | 2005-09-26 |
Family
ID=32685467
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20053624A NO20053624L (no) | 2002-12-27 | 2005-07-26 | Tetrahydro-4H-pyrido [1,2-A] pyrimidiner og beslektede forbindelser som er anvendbare som HIV-integrase inhibitorer |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US7414045B2 (de) |
| EP (1) | EP1578748B1 (de) |
| JP (1) | JP4733986B2 (de) |
| KR (1) | KR20050087865A (de) |
| CN (1) | CN100343253C (de) |
| AT (1) | ATE481401T1 (de) |
| AU (2) | AU2003292436B2 (de) |
| BR (1) | BR0317749A (de) |
| CA (1) | CA2509554C (de) |
| DE (1) | DE60334248D1 (de) |
| EC (1) | ECSP055890A (de) |
| HR (1) | HRP20050593A2 (de) |
| IS (1) | IS7892A (de) |
| MA (1) | MA27583A1 (de) |
| MX (1) | MXPA05007010A (de) |
| NO (1) | NO20053624L (de) |
| NZ (1) | NZ540729A (de) |
| PL (1) | PL377354A1 (de) |
| RU (1) | RU2329265C2 (de) |
| WO (2) | WO2004058756A1 (de) |
Families Citing this family (59)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004062613A2 (en) * | 2003-01-13 | 2004-07-29 | Bristol-Myers Squibb Company | Hiv integrase inhibitors |
| WO2005041664A1 (en) * | 2003-10-20 | 2005-05-12 | Merck & Co., Inc. | Hydroxy pyridopyrrolopyrazine dione compounds useful as hiv integrase inhibitors |
| AR046938A1 (es) * | 2003-12-12 | 2006-01-04 | Merck & Co Inc | Procedimiento para preparar hexahidropirimido[1,2-a]azepin-2-carboxilatos y compuetos similares |
| TW200526635A (en) * | 2003-12-22 | 2005-08-16 | Shionogi & Co | Hydroxypyrimidinone derivative having HIV integrase inhibitory activity |
| US7273859B2 (en) * | 2004-05-12 | 2007-09-25 | Bristol-Myers Squibb Company | HIV integrase inhibitors: cyclic pyrimidinone compounds |
| US7115601B2 (en) | 2004-05-18 | 2006-10-03 | Bristol-Myers Squibb Company | HIV integrase inhibitors |
| US7176196B2 (en) | 2004-05-28 | 2007-02-13 | Bristol-Myers Squibb Company | Bicyclic heterocycles as HIV integrase inhibitors |
| US7192948B2 (en) | 2004-05-28 | 2007-03-20 | Bristol-Myers Squibb Company | Bicyclic heterocycles as HIV integrase inhibitors |
| US7173022B2 (en) | 2004-05-28 | 2007-02-06 | Bristol-Myers Squibb Company | Bicyclic heterocycles as HIV integrase inhibitors |
| US7157447B2 (en) | 2004-05-28 | 2007-01-02 | Bristol-Myers Squibb Company | Bicyclic heterocycles as HIV integrase inhibitors |
| WO2006060225A2 (en) * | 2004-11-23 | 2006-06-08 | Merck & Co., Inc. | Process for asymmetric synthesis of hexahydropyrimido[1,2-a] azepine-2-carboxamides and related compounds |
| EP1824957A4 (de) * | 2004-12-03 | 2011-02-09 | Merck Sharp & Dohme | Verwendung von atazanavir zur verbesserung der pharmakokinetik von durch ugt1a1 umgewandelte arzneimittel |
| MX2007006635A (es) * | 2004-12-03 | 2007-06-19 | Merck & Co Inc | Formulacion farmaceutica de inhibidores dela carboxamida vih integrasa que contienen una composicion que controla la velocidad de liberacion. |
| UA87884C2 (uk) * | 2004-12-03 | 2009-08-25 | Мерк Энд Ко., Инк. | Безводна кристалічна калієва сіль інгібітора віл-інтегрази |
| EP3165220B2 (de) | 2004-12-03 | 2024-11-13 | Merck Sharp & Dohme LLC | Pharmazeutische zusammensetzung mit anti-keimbildner |
| WO2006088173A1 (ja) * | 2005-02-21 | 2006-08-24 | Shionogi & Co., Ltd. | Ｈｉｖインテグラーゼ阻害活性を有する２環性カルバモイルピリドン誘導体 |
| AU2006228278C1 (en) * | 2005-03-31 | 2011-06-23 | Msd Italia S.R.L. | HIV integrase inhibitors |
| US8129385B2 (en) | 2005-04-28 | 2012-03-06 | Shionogi & Co., Ltd. | Substituted 5-hydroxy-3,4,6,9,9a, 10-hexanhydro-2h-1-oxa04a,8a-diaza-anthracene-6,10-dioness |
| WO2007005404A1 (en) | 2005-06-30 | 2007-01-11 | Wyeth | AMINO-5-(6-MEMBERED)HETEROARYLIMIDAZOLONE COMPOUNDS AND THE USE THEREOF FOR ß-SECRETASE MODULATION |
| US7494984B2 (en) * | 2005-08-31 | 2009-02-24 | Bristol-Myers Squibb Company | Substituted imidazo[1,2-a]pyrimidines as HIV viral DNA integrase inhibitors |
| WO2007039218A1 (en) * | 2005-10-04 | 2007-04-12 | Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa | Hiv integrase inhibitors |
| AU2006306355A1 (en) * | 2005-10-27 | 2007-05-03 | Merck & Co., Inc. | HIV integrase inhibitors |
| EP1950212B1 (de) * | 2005-10-27 | 2016-02-24 | Shionogi Co., Ltd. | Polycyclisches carbamoylpyridonderivat mit hemmender wirkung auf hiv-integrase |
| WO2007059125A2 (en) * | 2005-11-15 | 2007-05-24 | Bristol-Myers Squibb Company | Hiv integrase inhibitors |
| WO2007058646A1 (en) * | 2005-11-15 | 2007-05-24 | Bristol-Myers Squibb Company | Hiv integrase inhibitors: cyclic pyrimidinone compounds |
| US7902182B2 (en) * | 2005-11-16 | 2011-03-08 | Bristol-Myers Squibb Company | HIV integrase inhibitors |
| US8039458B2 (en) * | 2005-11-17 | 2011-10-18 | Bristol-Myers Squibb Company | HIV integrase inhibitors |
| WO2007064316A1 (en) * | 2005-11-30 | 2007-06-07 | Bristol-Myers Squibb Company | Bicyclic heterocycles as hiv integrase inhibitors |
| US20070129379A1 (en) * | 2005-12-01 | 2007-06-07 | Bristol-Myers Squibb Company | Hiv integrase inhibitors |
| US20090136570A1 (en) * | 2006-01-20 | 2009-05-28 | Bhagwant Rege | Taste-Masked Tablets and Granules |
| WO2007143446A1 (en) * | 2006-05-30 | 2007-12-13 | Bristol-Myers Squibb Company | Spiro-condensed heterotricyclic compounds as hiv integrase inhibitors |
| US7893055B2 (en) * | 2006-06-28 | 2011-02-22 | Bristol-Myers Squibb Company | HIV integrase inhibitors |
| US7763630B2 (en) * | 2007-06-06 | 2010-07-27 | Bristol-Myers Squibb Company | HIV integrase inhibitors |
| US8129398B2 (en) * | 2008-03-19 | 2012-03-06 | Bristol-Myers Squibb Company | HIV integrase inhibitors |
| CA2738814C (en) * | 2008-10-06 | 2014-01-28 | Merck Sharp & Dohme Corp. | Hiv integrase inhibitors |
| EP3210603A1 (de) * | 2008-12-11 | 2017-08-30 | Shionogi & Co., Ltd | Synthese von carbamoylpyridon-hiv-integrase-hemmern und zwischenprodukte |
| US8143244B2 (en) * | 2009-02-26 | 2012-03-27 | Bristol-Myers Squibb Company | Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors |
| BRPI1015943A8 (pt) * | 2009-07-02 | 2018-01-09 | Sanofi Sa | derivados de 1,2,3,4-tetra - hidro - pirimido {1,2-a} pirimidin-6-ona, o respectivo preparo e a respectiva utilização farmacêutica. |
| CA2777664C (en) | 2009-10-13 | 2014-06-10 | Johannes Wilhelmus J. Thuring | Macrocyclic integrase inhibitors |
| US8383639B2 (en) | 2009-10-15 | 2013-02-26 | Bristol-Myers Squibb Company | HIV integrase inhibitors |
| BR112012009857A8 (pt) | 2009-10-26 | 2023-04-11 | Merck Sharp & Dohme | Composições farmacêuticas sólidas contendo um inibidor de integrase |
| BR112012024796A2 (pt) | 2010-04-02 | 2016-06-07 | Janssen R&D Ireland | inibidores de integrase macrocíclicos |
| UA112517C2 (uk) | 2010-07-06 | 2016-09-26 | Новартіс Аг | Тетрагідропіридопіримідинові похідні |
| AP3849A (en) | 2011-12-15 | 2016-09-30 | Novartis Ag | Use of inhibitors of the activity or function of pi3k |
| US9714243B2 (en) | 2012-12-17 | 2017-07-25 | Merck Sharp & Dohme Corp. | 4-pyridinonetriazine derivatives as HIV integrase inhibitors |
| US9493479B2 (en) | 2013-04-16 | 2016-11-15 | Merck Sharp & Dohme Corp. | Substituted pyrido[1,2-a]pyrazines as HIV integrase inhibitors |
| EP3330272B1 (de) | 2013-05-17 | 2021-02-17 | Merck Sharp & Dohme Corp. | Kondensierte tricyclische heterocyclische verbindungen als hiv-integrase-hemmer |
| WO2014200880A1 (en) | 2013-06-13 | 2014-12-18 | Merck Sharp & Dohme Corp. | Fused tricyclic heterocyclic compounds as hiv integrase inhibitors |
| KR102102516B1 (ko) | 2013-09-27 | 2020-04-20 | 머크 샤프 앤드 돔 코포레이션 | Hiv 인테그라제 억제제로서 유용한 치환된 퀴놀리진 유도체 |
| WO2016187788A1 (en) | 2015-05-25 | 2016-12-01 | Merck Sharp & Dohme Corp. | Fused tricyclic heterocyclic compounds useful for treating hiv infection |
| WO2017087257A1 (en) | 2015-11-17 | 2017-05-26 | Merck Sharp & Dohme Corp. | Amido-substituted pyridotriazine derivatives useful as hiv integrase inhibitors |
| WO2017106071A1 (en) | 2015-12-15 | 2017-06-22 | Merck Sharp & Dohme Corp. | Spirocyclic quinolizine derivatives useful as hiv integrase inhibitors |
| WO2017113288A1 (en) | 2015-12-31 | 2017-07-06 | Merck Sharp & Dohme Corp. | Fused tricyclic heterocyclic compounds as hiv integrase inhibitors |
| EP3548031B1 (de) | 2016-12-02 | 2023-07-19 | Merck Sharp & Dohme LLC | Als hiv-integrase-hemmer nützliche tetracyclische heterocyclenverbindungen |
| JOP20190130A1 (ar) | 2016-12-02 | 2019-06-02 | Merck Sharp & Dohme | مركبات حلقية غير متجانسة رباعية الحلقات مفيدة كمثبطات إنزيم مدمج لفيروس نقص المناعة البشرية (hiv) |
| US10786488B2 (en) | 2017-01-26 | 2020-09-29 | Merck Sharp & Dohme Corp. | Substituted quinolizine derivatives useful as HIV integrase inhibitors |
| AU2019277547B2 (en) | 2018-05-31 | 2024-10-10 | Shionogi & Co., Ltd. | Polycyclic pyridone derivative |
| PE20251594A1 (es) | 2018-05-31 | 2025-06-16 | Shionogi & Co | Derivado policiclico de carbamoilpiridona |
| US12577241B2 (en) | 2019-11-28 | 2026-03-17 | Shionogi & Co., Ltd. | Polycyclic pyridopyrazine derivative |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6262055B1 (en) | 1998-06-03 | 2001-07-17 | Merck & Co., Inc. | HIV integrase inhibitors |
| US6306891B1 (en) | 1998-06-03 | 2001-10-23 | Merck & Co., Inc. | HIV integrase inhibitors |
| US6380249B1 (en) | 1998-06-03 | 2002-04-30 | Merck & Co., Inc. | HIV integrase inhibitors |
| JP2003503386A (ja) | 1999-06-25 | 2003-01-28 | メルク エンド カムパニー インコーポレーテッド | １−（芳香族またはヘテロ芳香族置換）−３−（ヘテロ芳香族置換）−１，３−プロパンジオン類およびそれの使用 |
| EP1289993B9 (de) | 2000-06-07 | 2008-08-20 | Vertex Pharmaceuticals Incorporated | Caspase-inhibitoren und ihre verwendungen |
| GB0017676D0 (en) | 2000-07-19 | 2000-09-06 | Angeletti P Ist Richerche Bio | Inhibitors of viral polymerase |
| CA2321348A1 (en) * | 2000-09-27 | 2002-03-27 | Blaise Magloire N'zemba | Aromatic derivatives with hiv integrase inhibitory properties |
| US6841558B2 (en) | 2000-10-12 | 2005-01-11 | Merck & Co., Inc. | Aza-and polyaza-naphthalenyl carboxamides useful as HIV intergrase inhibitors |
| CA2425395C (en) | 2000-10-12 | 2009-06-02 | Merck & Co., Inc. | Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors |
| US20050010048A1 (en) | 2000-10-12 | 2005-01-13 | Linghang Zhuang | Aza-and polyaza-naphthalenly ketones useful as hiv integrase inhibitors |
| IL155089A0 (en) | 2000-10-12 | 2003-10-31 | Merck & Co Inc | Aza and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors |
| DK3042894T1 (da) | 2001-08-10 | 2016-11-07 | Shionogi & Co | Antiviralt middel |
| DK1441734T3 (da) | 2001-10-26 | 2007-06-11 | Angeletti P Ist Richerche Bio | Dihydroxypyrimidin-carboxamid-inhibitorer a HIV-integrase |
| CN102229605B (zh) | 2001-10-26 | 2015-01-14 | Msd意大利有限公司 | 关于hiv整合酶的n-取代的羟基嘧啶酮甲酰胺抑制剂 |
| AU2003216049B2 (en) | 2002-01-17 | 2008-07-17 | Merck Sharp & Dohme Corp. | Hydroxynaphthyridinone carboxamides useful as HIV integrase inhibitors |
| AU2003248872A1 (en) | 2002-07-09 | 2004-01-23 | Bristol-Myers Squibb Company | Hiv integrase inhibitors |
| WO2004062613A2 (en) | 2003-01-13 | 2004-07-29 | Bristol-Myers Squibb Company | Hiv integrase inhibitors |
| US7037908B2 (en) | 2003-04-24 | 2006-05-02 | Bristol-Myers Squibb Company | HIV integrase inhibitors |
| AR046938A1 (es) * | 2003-12-12 | 2006-01-04 | Merck & Co Inc | Procedimiento para preparar hexahidropirimido[1,2-a]azepin-2-carboxilatos y compuetos similares |
-
2003
- 2003-12-18 EP EP03768014A patent/EP1578748B1/de not_active Expired - Lifetime
- 2003-12-18 AU AU2003292436A patent/AU2003292436B2/en not_active Ceased
- 2003-12-18 RU RU2005123807/04A patent/RU2329265C2/ru not_active IP Right Cessation
- 2003-12-18 AT AT03768014T patent/ATE481401T1/de not_active IP Right Cessation
- 2003-12-18 US US10/540,449 patent/US7414045B2/en not_active Expired - Lifetime
- 2003-12-18 KR KR1020057012028A patent/KR20050087865A/ko not_active Ceased
- 2003-12-18 CN CNB2003801099211A patent/CN100343253C/zh not_active Expired - Fee Related
- 2003-12-18 AU AU2003292437A patent/AU2003292437A1/en not_active Abandoned
- 2003-12-18 BR BR0317749-1A patent/BR0317749A/pt not_active IP Right Cessation
- 2003-12-18 DE DE60334248T patent/DE60334248D1/de not_active Expired - Lifetime
- 2003-12-18 NZ NZ540729A patent/NZ540729A/en unknown
- 2003-12-18 WO PCT/GB2003/005536 patent/WO2004058756A1/en not_active Ceased
- 2003-12-18 HR HR20050593A patent/HRP20050593A2/hr not_active Application Discontinuation
- 2003-12-18 PL PL377354A patent/PL377354A1/pl not_active Application Discontinuation
- 2003-12-18 WO PCT/GB2003/005543 patent/WO2004058757A1/en not_active Ceased
- 2003-12-18 JP JP2004563339A patent/JP4733986B2/ja not_active Expired - Fee Related
- 2003-12-18 CA CA2509554A patent/CA2509554C/en not_active Expired - Fee Related
- 2003-12-18 MX MXPA05007010A patent/MXPA05007010A/es active IP Right Grant
-
2005
- 2005-06-13 IS IS7892A patent/IS7892A/is unknown
- 2005-06-23 EC EC2005005890A patent/ECSP055890A/es unknown
- 2005-07-21 MA MA28407A patent/MA27583A1/fr unknown
- 2005-07-26 NO NO20053624A patent/NO20053624L/no not_active Application Discontinuation
-
2008
- 2008-03-12 US US12/075,514 patent/US7968553B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE60334248D1 (de) | 2010-10-28 |
| US20080176869A1 (en) | 2008-07-24 |
| CN1753892A (zh) | 2006-03-29 |
| US7968553B2 (en) | 2011-06-28 |
| US20060046985A1 (en) | 2006-03-02 |
| BR0317749A (pt) | 2005-11-22 |
| PL377354A1 (pl) | 2006-01-23 |
| RU2329265C2 (ru) | 2008-07-20 |
| MA27583A1 (fr) | 2005-10-03 |
| HRP20050593A2 (en) | 2006-03-31 |
| US7414045B2 (en) | 2008-08-19 |
| IS7892A (is) | 2005-06-13 |
| AU2003292436B2 (en) | 2009-07-30 |
| RU2005123807A (ru) | 2006-01-20 |
| WO2004058757A1 (en) | 2004-07-15 |
| MXPA05007010A (es) | 2005-08-18 |
| AU2003292437A1 (en) | 2004-07-22 |
| ECSP055890A (es) | 2005-09-20 |
| JP4733986B2 (ja) | 2011-07-27 |
| NZ540729A (en) | 2008-03-28 |
| AU2003292436A1 (en) | 2004-07-22 |
| CA2509554C (en) | 2011-02-01 |
| EP1578748A1 (de) | 2005-09-28 |
| EP1578748B1 (de) | 2010-09-15 |
| JP2006513200A (ja) | 2006-04-20 |
| KR20050087865A (ko) | 2005-08-31 |
| CN100343253C (zh) | 2007-10-17 |
| ATE481401T1 (de) | 2010-10-15 |
| WO2004058756A1 (en) | 2004-07-15 |
| NO20053624D0 (no) | 2005-07-26 |
| CA2509554A1 (en) | 2004-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20053624D0 (no) | Tetrahydro-4H-pyrido [1,2-A] pyrimidiner og beslektede forbindelser som er anvendbare som HIV-integrase inhibitorer | |
| NO2020026I1 (no) | Raltegravir eller et farmasøytisk akseptabelt salt derav, spesielt kaliumsaltet | |
| DK1441734T3 (da) | Dihydroxypyrimidin-carboxamid-inhibitorer a HIV-integrase | |
| WO2005086700A3 (en) | Hiv integrase inhibitors | |
| WO2006103399A8 (en) | Hiv integrase inhibitors | |
| WO2007146230A3 (en) | Non-nucleoside reverse transcriptase inhibitors | |
| WO2004024078A3 (en) | Dihydroxypyridopyrazine-1,6-dione compounds useful as hiv integrase inhibitors | |
| WO2005120516A3 (en) | Hiv integrase inhibitors | |
| WO2007050510A3 (en) | Hiv integrase inhibitors | |
| ATE517899T1 (de) | Hiv-integrasehemmer | |
| WO2004047725A3 (en) | 8-hydroxy-1-oxo-tetrahydropyrrolopyrazine compounds useful as hiv integrase inhibitors | |
| WO2007002458A3 (en) | Non-nucleoside reverse transcriptase inhibitors | |
| WO2007002481A3 (en) | Non-nucleoside reverse transcriptase inhibitors | |
| WO2007002368A3 (en) | Non-nucleoside reverse transcriptase inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |